Who invested in Ambrx?
Ambrx's investors include Versant Ventures, 5AM Ventures, CMEA Ventures, Maverick Capital and Aravis Ventures, and 4 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$55Mraised across 2 rounds since 2009, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by onbiovc.comSEC filing: $10M sold, first sale Mar 2009
From the SEC filings it signed: 6 on the team.
On the board, as filediAllan MarchingtonAugust M. WatanabeDavid B. SingerJohn D. DiekmanPeter G. SchultzRichard D. DiMarchiShehan Dissanayake
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ambrx's investors include Versant Ventures, 5AM Ventures, CMEA Ventures, Maverick Capital and Aravis Ventures, and 4 more on record.
Ambrx has raised $55M across 2 rounds since 2009.
Ambrx's most recent round was an Undisclosed round of $45M in Aug 2016.
Its most recent round, $45M in Aug 2016, is also its largest on record.
Ambrx's first round on record, in Apr 2009, was backed by Versant Ventures, 5AM Ventures and CMEA Ventures and 4 others.
Ambrx's latest named round is an Undisclosed round, in Aug 2016.
Ambrx is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.